Objectives To assess cervical length (CL) 
INTRODUCTION
Preterm delivery (PTD) is a major obstetric complication associated with high mortality and morbidity, and the risk of perinatal complication is inversely related to gestational age at delivery. The most severe consequences occur in PTD before 34 weeks of gestation. The survival probability increases from less than 50% before 24 weeks of gestation to more than 95% by 33 weeks, with a corresponding inverse relationship between risk of disability in those fetuses that survive and gestational age at delivery 1, 2 . While improvements in neonatal care have led to higher survival rates of very premature infants, the most important impact on mortality and morbidity is related to the ability to predict and prevent PTD.
Although the pathophysiology of spontaneous PTD is multifactorial, measurement of cervical length (CL) on transvaginal ultrasound in the second trimester has been shown to be one of the best predictors [3] [4] [5] , with the risk of PTD being inversely associated with CL. Moreover, randomized trials have shown that, in women with a short cervix, administration of progesterone or use of cervical pessary starting from the second trimester reduces risk of PTD by 40% [6] [7] [8] [9] . Screening strategies earlier on in pregnancy could potentially increase the effectiveness of these preventive treatments. Combined first-trimester screening (cFTS) provides a unique opportunity to assess the effectiveness of first-trimester CL as a screening tool for PTD, although there is conflicting evidence regarding its predictive value [10] [11] [12] [13] [14] [15] [16] . However, recent single-center studies focusing on endocervical length suggest an association between first-trimester CL and PTD 12, 13, 17, 18 . The aims of this study were to assess CL longitudinally between the first and second trimesters and to determine the proportion of women with short CL. The study also aimed to assess if women with short CL at 19-24 weeks' gestation could be identified on transvaginal ultrasound at 11-14 weeks' gestation, in order to assess the potential value of implementation of universal CL screening for prediction of PTD in a Danish population.
METHODS
Women were recruited to this longitudinal prospective study between 1 November 2013 and 1 December 2014 at three large centers of fetal medicine in Denmark (Rigshospitalet, Copenhagen University Hospital; Aarhus University Hospital, Skejby; and Aalborg University Hospital). Asymptomatic women with a live singleton pregnancy attending for cFTS at 11-14 weeks were eligible. Exclusion criteria were: age < 18 years; uterine anomaly; cerclage; unable to speak or understand Danish; and progesterone treatment at inclusion. All participants gave written informed consent before enrolment. The study was approved by the Ethics Committee (H-1-2013-017) and the Danish Data Protection Agency .
In Denmark, all pregnant women are offered two routine scans: cFTS at 11-14 weeks' gestation and a second-trimester ultrasound scan for fetal abnormality at 19-21 weeks' gestation, with an uptake of more than 90% for both examinations 19 . Written information was given at the time of booking cFTS in order to give the women at least 1 week to decide on whether to participate, before inclusion at the time of cFTS.
Participants were assigned to transvaginal sonographic CL measurement at the 11-14-week cFTS (Cx1), the 19-21-week anomaly scan (Cx2) and at 23-24 weeks' gestation (Cx3) (at which time fetal growth was assessed).
A standardized management protocol was followed at all three participating centers. This protocol recommended that a maternal-fetal medicine specialist be consulted in case of a short first-trimester cervix (Cx1 ≤ 25 mm), and that the CL measurement be repeated after 1-2 weeks. Likewise, women with Cx2 or Cx3 ≤ 25 mm were referred to a maternal-fetal medicine specialist and treated with vaginal progesterone (100-200 mg/day) and/or cervical pessary, at the discretion of the specialist in charge. In some cases of CL 21-25 mm, women were offered a repeat CL measurement after 1-2 weeks, before deciding on treatment. In some cases of very short CL (≤ 15 mm), cerclage was indicated.
Information on maternal characteristics, including age, weight, mode of conception, smoking, obstetric history and prior cervical conization, was recorded at inclusion in the local Astraia databases (Astraia Software GmbH, Munich, Germany). Data on first-trimester biomarkers (free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A levels), nuchal translucency thickness and anomaly scans were entered in Astraia. Assessment of gestational age was based on crown-rump length on cFTS.
Measurement of CL
Measurement of CL on transvaginal sonography was performed according to Fetal Medicine Foundation (FMF) guidelines 20 using a Voluson E8 ultrasound machine (GE Medical Systems, Zipf, Austria) with a 5-9-MHz probe. Women were asked to empty their bladder and then placed in the dorsal lithotomy position (gynecological position). The transducer was introduced into the anterior fornix. After having identified the entire length of the cervical canal in the sagittal plane, the position and pressure of the probe were adjusted and the magnification of the ultrasound image was optimized by obtaining the widest angle with the cervix occupying 50-75% of the image. Care was taken to visualize clearly the cervical canal without excessive pressure being applied to the cervix in order to avoid artificial lengthening. CL was measured as the linear distance between the two ends of the glandular area around the endocervical canal. In order to avoid inclusion of the isthmus (lower uterine segment) in the measurement of endocervical length, care was taken to identify the internal os as well as the external cervical os. The point at which the cervical mucosa ends was considered to be the internal cervical os and the external os was identified as the point at which the anterior and posterior lips of the cervix come together. On first-trimester measurement (Cx1), the length of the isthmus was measured and recorded separately. The shortest CL measurement was recorded after 3-5 min of transvaginal sonography. Transfundal pressure was applied in order to note adverse dynamics and funneling of the cervix.
All measurements were performed by trained sonographers or by the first author (C.B.W.). In addition, ultrasound images were reviewed before data analysis by a single investigator (C.B.W. in consultation with one of the senior authors) to ensure that measurements were made appropriately and consistently. Outcome of pregnancy was unknown at the time of image review. Images that did not meet the quality criteria were excluded from analyses.
Outcome and definition of spontaneous PTD
Data on pregnancy outcome, including information on onset of labor, mode of delivery, birth weight and Apgar score, were retrieved from local birth databases or patient files. The records of all women delivering before 37 weeks were examined to assess whether PTD was spontaneous, defined as spontaneous onset of labor or preterm rupture of membranes.
Statistical analysis
The sample size calculation was based on Souka et al. 17 , who reported that 5% of pregnant women have a short (≤ 27 mm) CL at 11-14 weeks and that, among these women, the risk of a short (≤ 15 mm) CL at 20-24 weeks is 6%, in contrast with a risk of 1% for those with CL > 27 mm. To detect a difference in the risk of a short CL at weeks 20-24 with a power of 90% and a significance level of 5%, the necessary number of pregnant women was estimated to be 2880 using Fisher's exact test. As a dropout rate of 15% was hypothesized, a total of 3400 pregnant women were needed for inclusion.
Participants and decliners were compared with respect to maternal and pregnancy characteristics at cFTS using Pearson's chi-square test for categorical variables and Student's t-test or Wilcoxon rank-sum test for continuous variables, as appropriate. McNemar's test was used for comparing the proportion of women at different time points. For the cohort of women with first-and second-trimester CL measurements, the risk of short CL in the second trimester at various CL cut-off points (≤ 25 mm, ≤ 20 mm and ≤ 15 mm) was assessed according to first-trimester CL using logistic regression. Cx1 was used as a quantitative variable. The accuracy of predictions from this model, i.e. screening performance of first-trimester CL, was determined by receiver-operating characteristics (ROC) curve analysis. Predictive accuracy was further compared with the accuracy of models incorporating previous PTD and/or prior cervical conization. Finally, detection rates (DR) were calculated for a fixed false-positive rate (FPR) of 10%.
The proportion of women with short CL for various CL cut-offs at each scan and risk of spontaneous PTD are given with corresponding likelihood ratios (LR+). LR + indicates how much a given test result raises the odds of PTD, calculated as LR+ = sensitivity/FPR.
The association between short CL and rate of spontaneous PTD < 34 weeks was assessed using Cox regression with gestational age as the underlying time scale and delayed entry at the time of measurement of CL. In these analyses, competing events (induction of PTD) were censored. The proportional hazards assumption was assessed using the Kolmogorov-type supremum test 21 . Cumulative incidences of PTD were determined using the Aalen-Johansen estimator 22 . To evaluate CL screening in our population, numbers needed to screen (NNS) were calculated for different scenarios based on the number of cases with CL ≤ 25 mm and risk of PTD in our population as well as risk of PTD and the effect of progesterone treatment reported in recent literature 6 . The same analyses were performed for the population of women without previous PTD.
The level of significance was set at 5%. SAS version 9.4 (SAS Institute, Cary, NC, USA) and R version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria) were used for analyses.
RESULTS
During the study period, 4909 women with a singleton pregnancy at cFTS were informed about the study at the three participating centers. Among the 4904 women who fulfilled the inclusion criteria, 71% (n = 3477) agreed to participate (Figure 1 ). The three university hospital Total number of eligible women at cFTS
No further CL scans (n = 100) Moved hospital (n = 26) Miscarriage (n = 13) Termination (n = 10) Declined further CL scans (n = 31) Other reason (n = 20) Figure 1 Flowchart of study participants who underwent measurement of cervical length (CL) on transvaginal ultrasound at 11-14 (Cx1), 19-21 (Cx2) and 23-24 (Cx3) weeks' gestation. *Of 3477 women, 25 were not included in Cx1 analysis as images of CL did not meet quality criteria. †Of 3375 women, 41 were not included in Cx2 analysis as images of CL did not meet quality criteria or were missed by examiner. ‡Of 3302 women, three were not included in Cx3 analysis as images of CL did not meet quality criteria. §Cerclage due to adverse obstetric history. cFTS, combined first-trimester screening; IVF, in-vitro fertilization.
centers, Rigshospitalet, Aarhus and Aalborg, included 1504 (43.3%), 1029 (29.6%) and 944 (27.1%) women, respectively.
Baseline maternal and pregnancy characteristics of participants and decliners are shown in Table 1 . Women were more likely to participate if they were older (P < 0.0001), had a history of PTD (P < 0.0001), had prior cervical conization (P < 0.0001) or had conception by assisted reproductive technology (P < 0.0001). Women were more likely to decline to participate if they were a smoker (P = 0.001), parous (P < 0.0001) or not Caucasian (P = 0.04). The associations between CL and maternal characteristics are shown in Table S1 . A significant positive correlation was found for the relationships of Cx1 and Cx3 with maternal height, and significant negative correlations between CL measured on each scan and smoking, history of PTD and conization.
A total of 32 trained and certified sonographers each performed more than 50 CL scans per time point. Figure  S1 shows mean CL for all sonographers at the three time points. All examiners obtained mean CL measurement within 1 SD of the overall mean CL for each of the three measurements. Table 2 shows the distribution of longitudinal measurements of CL. Median gestational age was 90 (interquartile range (IQR), 87-92) days at Cx1, 139 (IQR, 137-141) days at Cx2 and 164 (IQR, 162-166) days at Cx3. Cx1 was obtained for 3452 women, and all three measurements were available for 3232 (93.0%) women. Histograms of the distribution of CL measurements are shown in Figure S2 . Median Cx1 was 37 (IQR, 34-41) mm, Cx2 was 40 (IQR, 36-43) mm and Cx3 was 40 (IQR, 36-43) mm. The lower uterine segment (isthmus) measured at the time of Cx1 was a median of 8.8 (IQR, 6.6-11.9) mm. In 10% of women, the isthmus was not measureable. The proportion of cases with funneling increased significantly from the first to second trimester (0.03% at Cx1, 0.66% at Cx2 and 1.06% at Cx3; P < 0.001). More than half of cases with funneling in the second trimester had CL ≤ 25 mm (13/22 at Cx2). Table 1 Maternal and pregnancy characteristics at combined first-trimester screening at 11-14 weeks' gestation of women with singleton pregnancy who participated in cervical-length measurement and those who declined Data are given as mean ± SD, n (%) or median (interquartile range). *Height < 130 cm or > 200 cm excluded. †Weight < 30 kg or > 250 kg excluded. β-hCG, beta-human chorionic gonadotropin; BMI, body mass index; MoM, multiples of the median; NT, nuchal translucency thickness; PAPP-A, pregnancy-associated plasma protein-A. 
Proportion and prediction of short CL
The proportion of women with short CL increased with gestational age: for CL ≤ 25 mm, from 0.41% (95% CI, 0.19-0.62%) at Cx1 to 1.79% (95% CI, 1.34-2.24%) at Cx3, and for CL ≤ 20 mm, from 0.03% (95% CI, 0.00-0.20%) at Cx1 to 0.85% (95% CI, 0.54-1.16%) at Cx3 (Table 2 ). In total, 26 (0.78%, 95% CI, 0.48-1.08%) women had CL ≤ 25 at Cx2 and an additional (i.e. with normal Cx2) 41 women at Cx3, corresponding to a total of 2.0% (95% CI, 1.51-2.51%) of women in the second trimester (Cx2 or Cx3), of which 38.8% were detected at Cx2. Risk of short CL was lower in the subgroup of women without previous PTD, as well as in the subgroup without any risk factors for PTD (previous PTD or prior cervical conization). In the subgroup of women without previous PTD, 24 (0.74%; 95% CI, 0.48-1.10%) women had CL ≤ 25 mm at Cx2 and an additional 35 women at Cx3, corresponding to a total of 1.8% (95% CI, 1.37-2.31%) at 19-24 weeks (Cx2 or Cx3). Only 14 (0.5%; 95% CI, 0.22-0.70%) women in the risk factor-free subgroup had a CL ≤ 25 mm at Cx2 and an additional 30 women at Cx3, corresponding to a total of 1.5% (95% CI, 1.01-1.92%) at Cx2 or Cx3. The probability of having a short cervix (≤ 25 mm, ≤ 20 mm or ≤ 15 mm) in the second trimester was inversely associated with Cx1 ( Figure 2 ). Women with Cx1 ≥ 35 mm had a very low (< 2%) probability of having a short second-trimester CL, in contrast to women with Cx1 ≤ 30 mm who had a markedly increased probability of having a short CL at 19-24 weeks. The probability of having a CL≤ 25 mm at 19-24 weeks was > 17% for women with Cx1 ≤ 25 mm, which is an almost nine-fold greater probability than for women with Cx1 ≤ 35 mm. The probability of having a short CL (≤ 25 mm, ≤ 20 mm or ≤ 15 mm) at 19-21 weeks or at 23-24 weeks according to CL at 11-14 weeks (Cx1) is given in Figure S3a and b.
ROC curve analyses showed that the DR of Cx1 ≤ 25 mm as a continuous variable for prediction of second-trimester CL ≤ 25 mm was 50.0% at a 10% FPR (area under the curve (AUC), 0.76 (95% CI, 0.70-0.83); Figure 3 ). There was no improvement on prediction of short second-trimester CL when history of PTD and prior cervical conization were incorporated into the Cx1 model (DR 50.5% at 10% false-positive rate; AUC, 0.78 (95% CI, 0.71-0.84)). The Cx1 cut-off corresponding to a DR of 50% was 31 mm. The AUC for short Cx1 for the prediction of CL ≤ 20 and ≤ 15 mm at 19-24 weeks is illustrated in Figure S4 , showing comparable AUCs with similar DRs (49.9% at a fixed FPR of 10% for Cx1 alone and 50.6% for the combined model including history of PTD and prior cervical conization). ROC curve analysis of the screening performance of Cx1 for the prediction of short CL at 19-21 weeks showed slightly lower sensitivities for a fixed FPR of 10% (data not shown).
Cervical length and spontaneous PTD
Pregnancy outcome was available for 3466/3477 women who had Cx1 recorded. There were 3434 (99.1%) live births, eight (0.2%) stillbirths, 13 (0.4%) miscarriages and 11 (0.3%) terminations. Outcome of pregnancy was unknown in 11 (0.3%) cases due to emigration. Among the 3442 live births and stillbirths, four (0.12%) women delivered spontaneously before 28 weeks, 29 (0.8%) women before 34 weeks and 114 (3.3%) women before 37 weeks. The proportion of spontaneous PTD was similar to that in the cohort of decliners; out of 1336 births, 12 (0.9%) women delivered spontaneously before 34 weeks and 42 (3.1%) women before 37 weeks.
Risk of spontaneous PTD was higher among women with a short CL in the second trimester. Table 3 shows the proportion of spontaneous PTDs before 28, 34 and 37 weeks' gestation and corresponding LR+ according to CL cut-off for first-and second-trimester measurements. Of the 67 women with Cx2 or Cx3 ≤ 25 mm, nine (13.4%) delivered spontaneously before 34 weeks and 17 (25.4%) before 37 weeks, with corresponding LR+ of 18 and 12, respectively. Six of the nine women who delivered before 34 weeks were diagnosed with CL ≤ 25 mm at 20 weeks (Cx2) and nearly 25% of women with Cx2 ≤ 25 mm delivered before 34 weeks ( Table 3 ). The effect of CL ≤ 25 mm on rate of PTD before 34 weeks estimated by Cox regression analysis showed a hazard ratio of 39.8 (95% CI, 16.2-97.7) for Cx2 ≤ 25 mm and 24.4 (95% CI, 11.2-53.6) for Cx2 or Cx3 ≤ 25 mm. The results of Cox regression analysis on the effect of short CL according to CL cut-off are given in Table S2 along with cumulative incidences.
The most common treatment for short second-trimester CL was vaginal progesterone. Of the 67 women with Cx2 or Cx3 ≤ 25 mm, 42 (62.7%) received vaginal progesterone and some were managed primarily or additionally with cerclage (n = 6) or pessary (n = 12) ( Table 4 ). Due to history of PTD, three women were treated with progesterone from 16 weeks. One of them subsequently had CL ≤ 25 mm at 20 weeks and the other two women had CL ≤ 25 mm at 23 weeks. Progesterone treatment was also started at 16 weeks in one woman due to a history of conization; she subsequently had CL ≤ 25 mm at 20 weeks. Twenty-three of the 67 cases (34.3%) did not receive any treatment. In these women, there was one case of Cx2 and 22 of Cx3 of 21-25 mm, and there was no further shortening of the cervix at *Four cases with short CL ≤ 25 mm at Cx2 did not have CL measurement at Cx3 due to delivery before Cx3 (n = 2) or follow-up at high-risk clinic instead; another four women with Cx2 ≤ 25 mm were treated with progesterone at Cx2 and did not have a CL ≤ 25 mm at Cx3. †Including one birth at 22 + 6 weeks; the baby died a few hours after birth. ‡Including one birth at 23 + 4 weeks; the baby died a few hours after birth. Data are n. *Rate of PTD < 34 weeks for CL cut-off 25 mm. †Corresponding to rate of PTD < 34 weeks in placebo group from meta-analysis of Romero et al. 6 . ‡Effect of progesterone, relative risk 0.66 according to Romero et al. 6 .
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follow-up CL measurement that indicated treatment should be initiated. No woman required progesterone treatment for Cx1 ≤ 25 mm. NNS for CL using transvaginal ultrasonography in the second trimester to prevent one case of spontaneous PTD before 34 weeks was calculated for CL screening at 19-21 weeks and at 19 + 0 to 24 + 6 weeks ( Table 5) . Calculations of NNS were based on the number of women with CL ≤ 25 mm in this study population, estimates of risk of PTD without treatment and effect of treatment with progesterone (relative risk 0.66) 6 . NNS was 1667 at 19-21 weeks and 556-1111 in the second trimester (19-24 weeks) in order to prevent one case of spontaneous PTD before 34 weeks.
A subgroup analysis was performed for women with and those without previous PTD (Tables S4-S7 and Figures S5 and S6 ). There was no difference in mean or median CL measured at each scan between the two populations (Table S4 ). Pregnancy outcome was available for 3367/3377 women without previous PTD who attended the first-trimester scan, and included 3335 (99.0%) live births, eight (0.2%) stillbirths, 13 (0.4%) miscarriages and 11 (0.3%) terminations. Outcome of pregnancy was lost to follow-up in 10 cases (0.3%) due to emigration. Among the 3343 live and stillbirths, four (0.1%) women delivered spontaneously before 28 weeks, 26 (0.8%) women before 34 weeks and 103 (3.1%) women before 37 weeks. The proportion of women delivering spontaneously before 28, 34 and 37 weeks of gestation was similar in the two populations and LR+ values for PTD were comparable (Table S5) . NNS was also comparable in the whole study population (n = 1667) and in the population without prior PTD (n = 1621) (Table S7) .
DISCUSSION
In this prospective multicenter study, CL was measured three times over the period 11-24 weeks' gestation, and it was demonstrated that, in a low-risk population of women with a singleton pregnancy, the proportion of CL ≤ 25 mm was low (0.4% at 11-14 weeks, 0.8% at 19-21 weeks and only 2.0% at 19-24 weeks). It was found that the probability of having a short second-trimester CL was higher for those with a short first-trimester CL. Nevertheless, the performance of first-trimester CL screening for the prediction of short CL at 19-24 weeks was poor (DR of 50% at a 10% FPR).
Recent single-center studies have suggested that first-trimester CL screening could be feasible for the prediction of early spontaneous PTD 12, 13, 16 , and focusing on the cervical canal alone has improved performance compared with previous studies 11, 14, 15 . Greco et al. 16 found that first-trimester CL and maternal characteristics detect 54.8% of PTD at a 10% FPR, while Souka et al. 12 found a similar DR of first-trimester CL screening (50%) but at a higher FPR (25%). We investigated the ability to predict a short cervix (≤ 25 mm) at 19-24 weeks. The value of first-trimester CL screening for the prediction of short second-trimester CL is in accordance with Souka et al. 17 , who reported a 40% DR at a 10% FPR for Cx1 alone for the prediction of short CL (≤ 15 mm) at 20-24 weeks. In contrast to the current study, they found a higher DR (68%) at a 10% FPR for a combined model of Cx1 and history of PTD.
In this study, when measuring CL to distinguish between the cervical canal and the lower uterine segment, care was taken to include only the endocervix 13, 23 . Nevertheless, median CLs in our study population were greater (37 and 40 mm in the first and second trimesters, respectively) than in previous studies focusing on the length of the endocervical canal 12, 13, 17, 18 . Souka et al. 17 and Greco et al. 13 reported median CLs between 31 and 34 mm, and the proportion of women with second-trimester CL < 15 mm was significantly higher (1.5% 17 and 0.9% 13 ). Some of this difference may be explained by differences in maternal characteristics associated with CL. Our population of mainly Caucasian women was taller and less likely to smoke or have a history of PTD.
As found in other studies, median CL did not change markedly from 11 to 24 weeks of gestation in the current study 12, 13, 24, 25 . The slightly shorter median CL in the first trimester compared with the second trimester can most likely be explained by the curved shape of the cervix in the first trimester. This is in accordance with a study by Kagan and Sonek 23 , who suggested that a highly curved cervix should be measured in segments to avoid underestimating CL. The slight increase in median CL is in contrast to other longitudinal CL studies 12, 13, 24, 25 ; this might be explained by a higher proportion of very curved cervices in the first trimester. Though the possibility of a systematic overestimation of CL cannot be excluded, this seems unlikely as care was taken to train and appropriately survey CL measurements, especially with respect to correct identification of the internal os.
In our cohort, the proportion of women with CL ≤ 25 mm at 19-24 weeks was lower than described by others [4] [5] [6] [7] [8] [9] 13, 17 . Two randomized trials evaluating vaginal progesterone treatment in women with a short CL had prevalence of short cervix of 1.7% 8 (CL < 15 mm) and 2.3% 7 (CL 10-20 mm), whereas we found prevalence to be 0.5% and 0.8% when using these cut-offs, respectively. Both trials had a high proportion of women with history of PTD (13-14%) and African-American ethnicity (32-52%), which may explain their higher proportion of short CL 7, 8 . A UK study of 1252 asymptomatic pregnant women at 23 weeks also reported a high prevalence of short CL 5 (1.7% for CL ≤ 15 mm, similar to Souka et al. 17 , and 8% for CL ≤ 25 mm). The lower proportion of women with short secondtrimester CL in this study is, however, in accordance with recent large studies on screening programs at 18-23 weeks [26] [27] [28] . In a low-risk population of 1569 women, 1.1% had CL < 20 mm and there was no difference in risk of spontaneous PTD between women undergoing and not undergoing screening 28 . Likewise, Miller et al. 27 reported a 0.9% incidence of CL ≤ 25 mm among 18 250 women at 20 weeks. Both studies 27, 28 excluded women with a history of PTD. In an unselected single-center population of 10 871 women at 17-23 weeks' gestation, the prevalence of CL ≤ 25 mm and ≤ 20 mm were 2.0% and 1.2%, respectively 26 , i.e. comparable to our findings. Furthermore, a Swedish study of 2122 women with CL measurement at 16-23 weeks also reported very low prevalence of CL ≤ 25 mm (0.5%) 29 . A possible limitation to our study is that more than 30 trained operators performed the CL measurements. On the other hand, this makes the study setting more comparable to daily practice. In addition, the intra-and interobserver reliability for CL measurement is high 30 , and the CL images were validated. An important strength of the study is the prospective design with repeat CL measurements between the first and second trimesters. The data on patients who declined to participate are important for evaluating aspects of implementing a CL screening program. Interestingly, rates of spontaneous PTD in participants and decliners were similar, despite the fact that the participant group had a higher proportion of women with previous PTD compared with the decliner group. These low rates were, however, comparable to rates reported previously 13, 31 . In accordance with other studies 4, 5 , the rate of spontaneous PTD was significantly higher in women with a short cervix.
Our data support the literature suggesting that universal CL screening in the second trimester may not be as cost-effective as believed previously, as it is highly dependent on the proportion of short CL and the rate of spontaneous PTD [26] [27] [28] 32 . In our population, if CL screening was implemented at the 19-21-week anomaly scan, the NNS to prevent one spontaneous PTD < 34 weeks was more than 1500 women.
In conclusion, we found an association between first-trimester CL and risk of short second-trimester CL. Once a short CL was observed, the risk of PTD was greatly increased. Whether universal CL screening should be implemented in our low-risk population must, however, depend on a cost-benefit analysis taking into account the low proportions of women with short CL and PTD.
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